Trehalose-6,6'-dibehenate

CAS : 66758-35-8

Ref. 3D-OT46136

Informations sur le produit

• Nom: Trehalose-6,6'-dibehenate
• Synonymes: TDB6,6'-Dibehenoyl-a,a'-trehalose, α-D-Glucopyranoside, 6-O-(1-oxodocosyl)-α-D-glucopyranosyl, 6-docosanoate, Trehalose 6,6′-dibehenate, Trehalose-6,6-dibehenate

Description

Trehalose-6,6'-dibehenate (TDB) is a novel synthetic lipid that has been shown to have beneficial effects in the treatment of inflammatory bowel disease. This compound may act as an anti-inflammatory agent by inhibiting toll-like receptor 4 (TLR4)-mediated signaling and TLR4-dependent production of proinflammatory cytokines. TDB also inhibits HIV infection by interfering with CD4+ T cell function and decreasing the number of CD4+ cells in the gut. In addition, TDB has been shown to be effective against lps-induced inflammatory response in cell culture.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 987.43 g/mol
• Formule: C₅₆H₁₀₆O₁₃
• Degré de pureté: One Spot
• Couleur/Forme: Powder